Sponsored Links
| ImmunoCellular Therapeutics Ltd. Expands Phase II Trial Of ICT-107 |
 |
 |
 |
| Medical News - Clinical Trials and Drug Trials | |||
|
ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company") (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107... Read more: Clinical Trials / Drug Trials News From Medical News Today
|